Skip to content
Screener

Unicycive Therapeutics, Inc. UNCY Q4 2025 Annual earnings

Reported March 30, 2026

EPS-$0.32Beat by $0.19
Revenue estimate$517.0K
EPS estimate-$0.51

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$902.8K
EPS estimate-$0.32

FAQ

When did Unicycive Therapeutics, Inc. report Q4 2025 earnings?
Unicycive Therapeutics, Inc. (UNCY) reported Q4 2025 earnings on March 30, 2026.
What were Unicycive Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Unicycive Therapeutics, Inc. reported eps of $-0.32 for Q4 2025.
Did Unicycive Therapeutics, Inc. beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.51 by $0.19.
How did Unicycive Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 100.0% from $-0.16.
Where can I find Unicycive Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001213900-26-035961) and the 10-K periodic report (0001213900-26-035903) directly on SEC EDGAR. The filing index links above go to sec.gov.